TIDMPXS

RNS Number : 8597O

Provexis PLC

04 October 2019

4 October 2019

Provexis plc

("Provexis" or the "Company")

Result of AGM

Provexis, the business that develops, licenses and sells the proprietary, scientifically-proven Fruitflow(R) heart-health functional food ingredient, announces that at the Company's Annual General Meeting, held earlier today, all resolutions were passed on a show of hands. The proxy votes received from shareholders on each resolution are set out below.

 
 Resolutions      Votes for        %   Votes against      %   Votes total   Votes withheld 
                          *                                            **              *** 
 Resolution 
  1             236,549,625    99.99          13,361   0.01   236,562,986          300,000 
 Resolution 
  2             236,275,612   100.00           1,240   0.00   236,276,852          586,134 
 Resolution 
  3             236,158,555    99.98          41,763   0.02   236,200,318          662,668 
 Resolution 
  4             236,275,612   100.00           1,240   0.00   236,276,852          586,134 
 Resolution 
  5             234,736,711    99.33       1,592,616   0.67   236,329,327          533,659 
 Resolution 
  6             231,213,811    97.85       5,088,982   2.15   236,302,793          560,193 
 Resolution 
  7             230,838,811    97.59       5,695,166   2.41   236,533,977          329,009 
 Resolution 
  8             235,036,711    99.45       1,292,616   0.55   236,329,327          533,659 
 
 
 *     Includes discretionary votes 
 **    Total votes cast do not include withheld votes 
 ***   A vote withheld is not a vote in law and is not counted 
        in the calculation of the proportion of votes 'For' or 
        'Against' any of the resolutions

For further information please contact:

 
 Provexis plc                  Tel: 07490 391888 
  Dawson Buck, Chairman         enquiries@provexis.com 
  Ian Ford, CEO & CFO 
 Allenby Capital Limited       Tel: 020 3328 5656 
  Nick Naylor / Liz Kirchner

Notes for editors

About Provexis plc

AIM-listed Provexis is focused on the development, licensing and sales of its proprietary, scientifically-proven Fruitflow(R) heart-health functional food ingredient.

Provexis was founded in 1999 and is headquartered in Reading, Berkshire.

Provexis shares are traded on the AIM market of the London Stock Exchange under the ticker symbol PXS.

For further information, please visit www.provexis.com and www.fruitflowplus.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGLZLFBKBFFFBD

(END) Dow Jones Newswires

October 04, 2019 08:19 ET (12:19 GMT)

Provexis (LSE:PXS)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024 Haga Click aquí para más Gráficas Provexis.
Provexis (LSE:PXS)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024 Haga Click aquí para más Gráficas Provexis.